C.R. Bard Acquires FlowCardia for Undisclosed Sum

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    745 North Pastoria Avenue Sunnyvale, CA 94085
  • Company Description
    FlowCardia, Inc. is a medical device company founded in 2002 to design and develop innovative technologies to facilitate the crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices and high restenosis rates of bare metal stents in CTOs have been major reasons the majority of CTO patients are still referred to medical management and bypass surgery.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Financial terms of the transaction were not disclosed

Trending on Xconomy